Air Pollution-Induced Vascular Endothelin Regulation of MMP Activity.
Air Pollution-Induced Vascular Endothelin Regulation of MMP Activity.
批准号:
7222181
负责人:
Amie Kathleen Lund
金额:
$4.6万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-09-01 至 2009-08-31
关键词:
air pollutionatherosclerosiscardiovascular disorder epidemiologycellular pathologydisease /disorder modelendothelinengine exhaustenvironmental exposureenzyme activityenzyme induction /repressionextracellular matrixfree radical oxygengene expressiongenetically modified animalshormone regulation /control mechanismlaboratory mousemetalloendopeptidasespathologic processpetroleum oilpolymerase chain reactionpostdoctoral investigatorvascular endothelium
中文摘要
描述(由申请人提供):动脉粥样硬化是一种与细胞外基质(ECM)的产生和降解以及动脉壁脂质蓄积相关的炎性疾病,是全球发病率和死亡率的主要原因。大量流行病学证据表明,颗粒和气体空气污染物与对人类健康的不利影响有关,特别是心血管事件发生率的增加。然而,吸入环境空气污染物对心血管疾病进展的影响所涉及的机制细胞和分子途径尚未阐明。动脉ECM的重塑是动脉粥样硬化进展中的关键步骤,其被认为主要通过基质金属蛋白酶(MMP)的表达和活性来调节。然而,尚未确定MMP活性是否参与与暴露于常见环境空气污染物相关的动脉粥样硬化的进展。该提案的目的是检验以下假设:长期暴露于环境空气污染物,特别是汽油发动机排放物,导致活性氧(ROS)上调,随后诱导参与动脉粥样硬化进展的分子途径。为了本文提出的实验的目的,我们将利用动脉粥样硬化倾向ApoE敲除小鼠的动物模型。在目的1中,将确定亚慢性暴露于汽油发动机废气是否导致MMP途径的上调和随后的激活,其与动脉粥样硬化的进展相关。为此,我们将研究MMP蛋白酶家族特定成员的表达和活性,这些成员先前已被发现在动脉粥样硬化的发病机制和进展中上调。在目标2中,我们将试图确定哪些途径参与诱导MMPs。具体来说,我们将针对ROS和血管活性肽内皮素-1(ET-1)的产生。此外,我们将确定ET-1表达是否是通过ROS(通过抗氧化治疗)途径介导的动脉粥样硬化血管暴露于汽油发动机排放。最后,在目的3中,将通过利用ET-1受体拮抗剂疗法结合暴露来确定ET-1是否直接调节MMP表达和活化。考虑到心血管疾病诊断和治疗对当今医疗保健的影响,确定哪些因素可能导致此类疾病的发作和/或进展至关重要。识别与心血管疾病进展相关的环境因素及其潜在的细胞途径对于预防和药物治疗都至关重要。
英文摘要
DESCRIPTION (provided by applicant): Atherosclerosis, an inflammatory disease associated with the production and degradation of the extracellular matrix (ECM) and accumulation of lipids in the arterial wall, is the leading cause of morbidity and mortality worldwide. Substantial epidemiological evidence indicates that particulate and gaseous air pollutants are associated with adverse human health effects, specifically increased rates of cardiovascular incidents. However, the mechanistic cellular and molecular pathways involved in the effects of inhaled environmental air pollutants on the progression of cardiovascular disease have not yet been elucidated. Remodeling of arterial ECM is a crucial step in the progression of atherosclerosis, which is thought to be primarily regulated through matrix metalloproteinase (MMP) expression and activity. However, it has not yet been determined whether MMP activity is involved in the progression of atherosclerosis in association with exposure to common environmental air pollutants. The goal of this proposal is to test the hypothesis that chronic exposure to environmental air pollutants, specifically gasoline engine emissions, results in upregulation of reactive oxygen species (ROS) and subsequent induction of molecular pathways involved in the progression of atherosclerosis. For the purpose of the experiments proposed, herein, we will utilize the animal model of atherosclerosis-prone ApoE knockout mice. In Aim 1, it will be determined whether subchronic exposure to gasoline engine exhaust results in upregulation and subsequent activation of the MMP pathway.which is associatiated with the progression of atherosclerosis. To do this, we will look at the expression and activity of specific members of the MMP proteinase family that have previously been found to be upregulated in the pathogenesis and progression of atherosclerosis. In Aim 2, we will attempt to identify which pathways are involved in induction of MMPs. Specifically we will target the production of ROS, and vasoactive peptide endothelin-1 (ET-1). Additionally, we will determine whether ET-1 expression is being mediated through a ROS (via antioxidant therapy) pathway in atherosclerotic vessels exposed to gasoline engine emission. Finally, in Aim 3, it will be determined whether ET-1 is directly regulating MMP expression and activation by utilizing an ET-1 receptor antagonist therapy in conjunction with the exposures. Considering the ramifications of cardiovascular disease diagnosis and treatment on health care today, it is critical to determine which factors may contribute to the onset and/or progression of such diseases. Identification of environmental factors, and the cellular pathways they potentate, associated with cardiovascular disease progression is critical for both prevention and pharmacological therapy.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The Renin-Angiotensin System in Air Pollution-Mediated Exacerbation of Obesity.
-
批准号:10654124
-
项目类别:
-
资助金额:$43.6万
-
财政年份:2023
-
负责人:Amie Kathleen Lund
-
依托单位:
The Renin-Angiotensin System in Air Pollution-Mediated Exacerbation of Obesity
-
批准号:9231794
-
项目类别:
-
资助金额:$43.8万
-
财政年份:2017
-
负责人:Amie Kathleen Lund
-
依托单位:
MMP-9 Activity Mediates Vascular Effects of Inhaled Environmental Air Pollutants
-
批准号:7916962
-
项目类别:
-
资助金额:$24.9万
-
财政年份:2009
-
负责人:Amie Kathleen Lund
-
依托单位:
MMP-9 Activity Mediates Vascular Effects of Inhaled Environmental Air Pollutants
-
批准号:7923996
-
项目类别:
-
资助金额:$24.9万
-
财政年份:2009
-
负责人:Amie Kathleen Lund
-
依托单位:
MMP-9 Activity Mediates Vascular Effects of Inhaled Environmental Air Pollutants
-
批准号:8116670
-
项目类别:
-
资助金额:$24.9万
-
财政年份:2009
-
负责人:Amie Kathleen Lund
-
依托单位:
MMP-9 Activity Mediates Vascular Effects of Inhaled Environmental Air Pollutants
-
批准号:8073757
-
项目类别:
-
资助金额:$1.43万
-
财政年份:2009
-
负责人:Amie Kathleen Lund
-
依托单位:
MMP-9 Activity Mediates Vascular Effects of Inhaled Environmental Air Pollutants
-
批准号:7448763
-
项目类别:
-
资助金额:$9.38万
-
财政年份:2008
-
负责人:Amie Kathleen Lund
-
依托单位:
Air Pollution-Induced Vascular Endothelin Regulation of MMP Activity.
-
批准号:7291004
-
项目类别:
-
资助金额:$3.83万
-
财政年份:2006
-
负责人:Amie Kathleen Lund
-
依托单位:
国内基金
海外基金
登录
查看更多内容
卡路里限制的T细胞糖脂代谢重塑机制及网络调控
-
批准号:91957111
-
项目类别:重大研究计划
-
资助金额:80.0万元
-
批准年份:2019
-
负责人:李佩盈
-
依托单位:
高尿酸血症促进动脉粥样硬化机制探讨
-
批准号:81170251
-
项目类别:面上项目
-
资助金额:14.0万元
-
批准年份:2011
-
负责人:刘梅林
-
依托单位:
磷脂转运蛋白通过磷酸鞘氨醇1影响高密度脂蛋白抗动脉粥样硬化功能的分子机制
-
批准号:81070247
-
项目类别:面上项目
-
资助金额:33.0万元
-
批准年份:2010
-
负责人:秦树存
-
依托单位:
大麻素CB2受体:巨噬细胞efferocytosis功能调控和不稳定斑块防治的新靶点
-
批准号:81000086
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2010
-
负责人:江立生
-
依托单位:
抑制PI3K/Akt/mTOR/p70S6K 信号通路促进巨噬细胞自体吞噬稳定易损斑块的分子机制研究
-
批准号:30971216
-
项目类别:面上项目
-
资助金额:31.0万元
-
批准年份:2009
-
负责人:陈文强
-
依托单位:
基因缺失突变抑制白细胞趋化稳定动脉粥样硬化易损斑块的研究
-
批准号:30871040
-
项目类别:面上项目
-
资助金额:32.0万元
-
批准年份:2008
-
负责人:陈文强
-
依托单位: